Clinical Trial Update: A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice [Phase 4]

View source ↗

Summary

Prospective observational Phase 4 trial assessing the effectiveness of new antiepileptic drugs as first adjunct therapy in daily practice for focal epilepsy; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Focal Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2010-07-23